Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB & Puliyel JM (2002) The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Child 87, 111–113.
Ahlawat SK, Singh MM, Kumar R, Kumari S & Sharma BK (2002) Time trends in the prevalence of hypertension and associated risk factors in Chandigarh. J Indian Med Assoc 100, 547–554.
Akinkugbe OO (1990) Epidemiology of cardiovascular disease in developing countries. J Hypertens 8, S233–S238.
Anonymous (1992) An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. People's Republic of China–United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. Circulation 85, 1083–1096.
Anonymous (2004) The catastrophic failures of public health. Lancet 363, 745.
Arunabh S, Pollack S, Yeh J & Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88, 157–161.
Atkinson J, Poitevin P, Chillon JM, Lartaud I & Levy B (1994) Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats. Am J Physiol 266, H540–H547.
Baedenkopf WG, Daoud AS & Love BM (1964) Calcification in the coronary arteries and its relationship to artheriosclerosis and myocardial infarction. Am J Roentgenol 92, 865–871.
Banks LM, Lees B, MacSweeney JE & Stevenson JC (1994) Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest 24, 813–817.
Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C & Chomka EV (1998) Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62, 209–213.
Bhattoa HP, Bettenbut P, Ganacharya S, & Balogh (2004) Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int 15, 447–451.
Block GA, Hulbert-Shearon TE, Levin NW & Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31, 607–617.
Block GA, Martin KJ, de Francisco AL et al. , (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350, 1516–1525.
Boucher BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome X? Br J Nutr 79, 315–327.
Bouillon RA, Auwerx JH, Lissens WD & Pelemanns WK (1987) Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 45, 755–763.
Canning MO, Grotenhuis K, de Wit H, Ruwhof C & Drexhage HA (2001) 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145, 351–357.
Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD & Meunier PJ (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab 81, 1129–1133.
Chiu KC, Chu A, Go VL & Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820–825.
Crawford VL, Sweeney O, Coyle PV, Halliday IM & Stout RW (2000) The relationship between elevated fibrinogen and markers of infection: a comparison of seasonal cycles. QJM 93, 745–750.
Davies MR & Hruska KA (2001) Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60, 472–479.
Davies PS, Bates CJ, Cole TJ, Prentice A & Clarke PC (1999) Vitamin D: seasonal and regional differences in preschool children in Great Britain. Eur J Clin Nutr 53, 195–198.
Dent CE, Engelbrecht HE & Godfrey RC (1968) Osteoporosis of lumbar vertebrae and calcification of abdominal aorta in women living in Durban. Br Med J 4, 76–79.
Docio S, Riancho JA, Perez A, Olmos JM, Amado JA & Gonzalez-Macias J (1998) Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res 13, 544–548.
Doherty TM & Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54, 224–230.
Douglas AS, Allan TM & Rawles JM (1991) Composition of seasonality of disease. Scott Med J 36, 76–82.
Douglas AS, Dunnigan MG, Allan TM & Rawles JM (1995) Seasonal variation in coronary heart disease in Scotland. J Epidemiol Commun Health 49, 575–582.
Elford J, Phillips AN, Thomson AG & Shaper AG (1989) Migration and geographic variations in ischaemic heart disease in Great Britain. Lancet i, 343–346.
Enquselassie F, Dobson AJ, Alexander HM & Steele PL (1993) Seasons, temperature and coronary disease. Int J Epidemiol 22, 632–636.
Enterline PE, Rikli AE & Sauer HI (1960) Death rates for coronary heart disease in metropolitan and other areas. Pub Health Rep 75, 759–766.
Evans AE, Ruidavets JB, McCrum E et al. , (1995) Autre pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse (WHO MONICA project). QJM 88, 469–477.
Federal Statistical Office (2003) Statistical Yearbook 2003 for Foreign Countries. Wiesbaden, Germany: Federal Statistical Office.
Fleck A (1989) Latitude and ischemic heart disease. Lancet i, 613.
Fraser JD, Otawara Y & Price PA (1988) 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. J Biol Chem 263, 911–916.
Frohlich M, Sund M, Russ S, Hoffmeister A, Fischer HG, Hombach V & Koenig W (1997) Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler Thromb Vasc Biol 17, 2692–2697.
Fujita T, Okamoto Y, Sakagami Y, Ota K & Ohata M (1984) Bone changes and aortic calcification in aging inhabitants of mountain versus seacoast communities in the Kii Peninsula. J Am Geriatr Soc 32, 124–128.
Fukagawa M & Kurokawa K (2005) Renal failure and secondary hyperparathyreodism. In Vitamin D, 2nd ed. pp. 1821–1831 [Feldman D, Pike JW and Glorieux FH, editors]. Amsterdam: The Netherlands: Elsevier Academic Press.
Gannage-Yared MH, Chemali R, Yaacoub N & Halaby G (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15, 1856–1862.
Gjonca A & Bobak M (1997) Albanian paradox, another example of protective effect of Mediterranean lifestyle? Lancet 350, 1815–1817.
Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P & Eriksen EF (2000) Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 247, 260–268.
Global Cardiovascular Infobase (2003) WHO Collaborating Centre for Surveillance of Cardiovascular Diseases. www.cvinfobase.a (Accessed 23 September 2003).
Gomez-Alonso C, Naves-Diaz MLFeernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT & Cannata-Andia JB (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 85, 44–48.
Gordan RS & Danner RN (1977) Coronary heart disease at high altitudes. N Engl J Med 297, 60–62.
Goswami R, Gupta N, Goswami D, Marwaha R, Tandon N & Kochupillai N (2000) Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 72, 472–475.
Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164, 371–377.
Grimes DS, Hindle E & Dyer T (1996) Sunlight, cholesterol and coronary heart disease. QJM 89, 579–589.
Grimes DS, Hindle E & Dyer T (2000) Respiratory infection and coronary heart disease: progression of a paradigm. QJM 93, 375–383.
Guillemant J, Le HT, Maria A, Allemandou A, Peres G & Guillemant S (2001) Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int 12, 875–879.
Gupta R (1996) Lifestyle risk factors and coronary heart disease prevalence in Indian men. J Assoc Physicians India 44, 689–693.
Gupta R, Prakash H & Kaul V (1997) Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan. J Assoc Physicians India 45, 275–279.
Halloran BP, Schaefer P, Lifschitz M, Levens M & Goldsmith RS (1984) Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab 59, 1063–1069.
Hass GM, Truehart RE, Taylor CB & Stumpe M (1958) An experimental histologic study of hypervitaminosis D. Am J Pathol 34, 395–431.
Heaney RP, Davies KM, Chen TC, Holick MF & Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204–210.
Hegarty V, Woodhouse P & Khaw KT (1994) Seasonal variation in 25-hydroxyvitamin D and parathyroid hormone concentrations in healthy elderly people. Age Ageing 23, 478–482.
Heinrich PC, Castell JV & Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265, 621–636.
Holick M (1995) Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61, Suppl., 638S–645S.
Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9, 87–98.
Hollenberg NK, Martinez G, McCullough M, Meinking T, Passan D, Preston M, Rivera A, Taplin D & Vicaria-Clement M (1997) Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 29, 171–176.
Honye J, Mahon DJ, Jain A, White CJ, Ramee SR, Wallis JB, Al-Zarka A & Tobis JM (1992) Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation 85, 1012–1025.
Hultgren HN (1970) Reduction of systemic arterial blood pressure at high altitude. Adv Cardiol 5, 49–55.
Ishimura E, Nishizawa Y, Inaba M et al. , (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55, 1019–27.
Juttmann JR, Buurman CJ, DeKam E, Visser TJ & Birkenhager JC (1981) Serum concentrations of metabolites of vitamin D in patients with chronic renal failure. Clin Endocrinol 14, 225–236.
Kamycheva E, Sundsfjord J & Jorde R (2004) Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil 11, 69–74.
Kent SP, Vawter GF, Dowben RM & Benson RE (1958) Hypervitaminosis D in monkeys: a clinical and pathological study. Am J Pathol 34, 37–59.
Kimura Y, Kawamura M, Owada M, Oshima T, Murooka M, Fujiwara T & Hiramori K (1999) Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med 38, 31–35.
Krause R, Buhring M, Hopfenmuller W, Holick MF & Sharma AM (1998) Ultraviolet B and blood pressure. Lancet 352, 709–710.
Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ & Valsta LM (2001) Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16, 2066–2073.
Lehtonen-Veromaa M, Mottonen T, Irjala K, Karkkainen M, Lamberg-Allardt C, Hakola P & Viikari J (1999) Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr 53, 746–751.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ & Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229–238.
Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH & Ljunghall S (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged. Am J Hypertens 8, 894–901.
Linhares ER, Jones DA, Round JM & Edwards RH (1984) Effect of nutrition on vitamin D status: studies on healthy and poorly nourished Brazilian children. Am J Clin Nutr 39, 625–630.
Lips P (2005) How to define normal values for serum concentrations of 25-hydroxyvitamin D? In Vitamin D 2nd ed. pp. 1019–1028 [Feldman D, Pike JW and Glorieux FH, editors]. Amsterdam, The Netherlands: Elsevier Academic Press.
Lips P, Graafmanns WC, Ooms ME, Bezemer PD & Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons. A randomised, placebo-controlled clinical trial. Ann Int Med 15, 400–406.
Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW & Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30, 771–777.
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR & Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78–81.
McKenna M (1992) Differences in vitamin D status between countries in young adults and elderly. Am J Med 93, 69–77.
Mallat Z, Besnard S, Duriez M et al. , (1999) Protective role of interleukin-10 in atherosclerosis. Circulation Res 85, E17–E24.
Margolis JR, Chen JT, Kong Y, Peter RH, Behar VS & Kisslo JA (1980) The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 137, 609–616.
Mavri A, Guzic-Salobir B, Salobir-Pajnic B, Keber I, Stare J & Stegnar M (2001) Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagul Fibrinolysis 12, 359–365.
Meier C, Woitge HW, Witte K, Lemmer B & Seibel MJ (2004) Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 19, 1221–1230.
Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ & Northfield TC (1997) Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78, 273–277.
Mims FM (1996) Significant reduction of UVB caused by smoke from biomass burning in Brazil. Photochem Photobiol 64, 814–816.
Mitnick MA, Grey A, Masiukiewicz U, Bartkiewicz M, Rios-Velez L, Friedman S, Xu L, Horowitz MC & Insogna K (2001) Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol 280, E405–E412.
Moon J, Bandy B & Davison AJ (1992) Hypothesis: are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 11, 567–583.
Mortimer EA, Monson RR & MacMahon B (1977) Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296, 581–585.
Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A & Bendtzen K (1992) 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506–512.
Muna WF (1993) Cardiovascular disorders in Africa. World Health Stat Q 46, 125–133.
Murray CJ & Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349, 1269–1276.
Passeri G, Pini G, Troiano L, Vescovini R, Sansoni P, Passeri M, Gueresi P, Delsignore R, Pedrazzoni M & Franceschi C (2003) Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 88, 5109–5115.
Pepe J, Romagnoli E, Nofroni I, Pacitti MT, De Geronimo S, Letizia C, Tonnarini G, Scarpiello A, D'Erasmo E & Minisola S (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 16, 805–812.
Pfeifer M, Begerow B, Minne HW, Nachtigall D & Hansen C (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86, 1633–1637.
Price PA, Faus SA & Williamson MK (2000) Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 20, 317–327.
Rajakumar K (2003) Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 112, E132–E135.
Ramchandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KN & Nair JD (2001) High prevalence of diabetes and impaired glucose tolerance in India. National urban diabetes survey. Diabetologia 9, 1094–1101.
Renaud S & de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–1526.
Ridker PM, Hennekens CH, Buring JE & Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836–843.
Rigel DS, Rigel EG & Rigel AC (1999) Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 40, 114–116.
Rostand SG (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.
Rostand SG & Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56, 383–392.
Rucker D, Allan JA, Fick GH & Harley DA (2002) Vitamin D insufficiency in a population of healthy western canadians. CMAJ 166, 1517–1524.
Schurgers LJ, Dissel PE, Spronk HM, Soute BA, Dhore CR, Cleutjens JP & Vermmer C (2001) Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol 90, Suppl. 3, 57–63.
Scragg R (1981) Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 10, 337–341.
Scragg R (1982) Seasonal variation in mortality in Queensland. Community Health Stud 6, 120–129.
Scragg R, Khaw KT & Murphy S (1995) Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 49, 640–646.
Shanahan CM & Weissberg PL (1998) Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thrombos Vasc Biol 18, 333–338.
Shi-Kuang P, Bruce TC, Philip T & Belma M (1976) Role of mild excess of vitamin D3 in arteriosclerosis: a study in squirrel monkeys. Arterial Wall 4, 229–249.
Shoji T, Shinohara K, Kimoto E et al. , (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19, 179–184.
Simpson RU & Weishaar RE (1988) Involvement of 1,25-dihydroxyvitamin D3 in regulating myocardial calcium metabolism: physiological and pathological actions. Cell Calcium 9, 285–292.
Singh RB, Niaz MA, Ghosh S, Beegom R, Agarwal P, Nangia S, Moshiri M & Janus ED (1998) Low fat intake and coronary artery disease in a population with higher prevalence of coronary artery disease: the Indian paradox. J Am Coll Nutr 17, 342–350.
Souci SW, Fachmann W & Kraut H (1994) Die Zusammensetzung der Lebensmittel - Nährwerttabellen (The Composition of Food – Tables of Nutritional Values). Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft.
Spiess TD (1932) Production of nonfatal vascular sclerosis in rabbits by means of viosterol (irradiated ergosterol). Arch Intern Med 50, 443–449.
Stack AG & Bloembergen WE (2001) Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12, 1516–1523.
Takeo S, Anan M, Fujioka K, Kajihara T, Hiraga S, Miyake K, Tanoka K, Minematsu R, Mori H & Taniguchi Y (1989) Functional changes of aorta with massive accumulation of calcium. Arteriosclerosis 77, 175–181.
Tangpricha V, Pearce EN, Chen TC & Holick MF (2002) Vitamin D insufficiency among free-living healthy young adults. Am J Med 112, 659–662.
Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna E, Price CP & Boucher BJ (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787–796.
van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L & Bouillon R (2003) Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88, 4623–4632.
Van Lente F (2000) Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 293, 31–52.
Vieth R (2002) Vitamin D ingestion and changes to rat aorta. Cardiovascular Res 56, 323–324.
Vieth R, Cole DE, Hawker GA, Trang HM & Rubin LA (2001) Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 55, 1091–1097.
Vieth R, Kimball S, Hu A & Walfish PG (2004) Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 3, 8.
Vieth R, Ladak Y & Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88, 185–191.
Vik T, Try K & Stromme JH (1980) The vitamin D status of man at 70 degrees north. Scand J Clin Lab Invest 40, 227–232.
Watson KE, Abroiat ML, Malone LL, Hoed JM, Doherty T, Detrano R & Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96, 1755–1760.
Woitge HW, Knothe A, Witte K, Schmidt-Gayk H, Ziegler R, Lemmer B & Seibel MJ (2000) Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 15, 2443–2450.
Wortsman J, Matsuoka LY, Chen TC, Lu Z & Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690–693.
Yancy WS Jr, Westman EC, French PA & Califf RM (2003) Diets and clinical coronary events: the truth is out there. Circulation 107, 10–16.
Yudkin JS, Yajnik CS, Mohamed-Ali V & Bulmer K (1999) High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care 22, 363–364.
Yusuf A, Reddy S, Ounpuu S & Anand S (2001) Global burden of cardiovascular diseases part I: General considerations, the epidemiologic transition, risk factors, and impact or urbanization. Circulation 104, 2746–2753.
Zittermann A (1987) Vitamin D Status von Patienten mit hereditären Aminosäurestoffwechselstörungen und von Patienten mit Phenylketonurie (Vitamin D status in patients with hereditary disturbances in amino acid metabolism and in patients with phenylketonuria). PhD Thesis, Bonn, Germany.
Zittermann A (2003 a) Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89, 552–572.
Zittermann A (2003 b) Serum 25-hydroxyvitamin D response to oral vitamin D intake in children. Am J Clin Nutr 78, 496–497.
Zittermann A, Dembinski J & Stehle P (2004) Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr Allergy Immunol 15, 242–246.
Zittermann A, Sabatschus O, Jantzen S, Platen P, Danz A, Dimitriou T, Scheld K, Klein K & Stehle P (2000) Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels in comparison to age-matched sedentary controls. Calcif Tissue Int 67, 215–219.
Zittermann A, Scheld K & Stehle P (1998) Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nutr 52, 501–506.
Zittermann A, Schulze Schleithoff S, Tenderich G, Berthold HK, Körfer R & Stehle P (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41, 105–112.